PET affects treatment in over a third of cancer cases

March 25, 2008 PET affects treatment in over a third of cancer cases James Brice -------------------------------------------------------------------------------- A study based on nearly 23,000 patients at 1200 U.S. healthcare facilities has found that FDG-PET or PET/CT led referring physicians to alter their opinion about the optimal treatment for about 37% of cancer patients. The results summarize the first-year experience of the National Oncology PET Registry, an effort that is measuring how numerous cancer-related PET applications that have conditional approval for Medicare payment influence patient management.

See full article and related articles at DiagnosticImaging.com
This article was republished with permission from CMPMedica, LLC